KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,706 | -22.6% | 190,825 | +3.4% | 0.06% | -53.6% |
| Q2 2023 | $330,468 | -95.5% | 184,619 | -52.6% | 0.12% | -74.0% |
| Q2 2020 | $7,383,000 | -18.6% | 389,807 | -17.4% | 0.48% | -39.6% |
| Q1 2020 | $9,071,000 | +44.2% | 472,182 | +43.9% | 0.80% | +54.8% |
| Q4 2019 | $6,290,000 | +61.2% | 328,118 | -19.1% | 0.52% | +92.9% |
| Q3 2019 | $3,902,000 | +55.0% | 405,617 | -3.5% | 0.27% | +62.8% |
| Q2 2019 | $2,518,000 | – | 420,372 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |